AIDS Treatment News Index, 1999

AIDS Treatment News Index, 1999
TopicDateIssueTitle of article
Aaron Diamond AIDS Research Center04-Jun-99#320Eradication or Immune Control: New Research, Issue of Focus
abacavir08-Jan-99#310Ziagen(TM) (Abacavir) Approved: Caution Essential
Abbott05-Nov-99#330Activism Today: The Coalition for Salvage Therapy. Interview with Linda Gr
Abbott Laboratories01-Oct-99#328ABT-378 Early Access Program Begins
ABT-37801-Oct-99#328ABT-378 Early Access Program Begins
ABT-37801-Oct-99#328ICAAC: New Drugs in Late Breaker Session
access to care17-Dec-99#333San Francisco General Hospital Funding Crisis: Call for Information
access to care19-Nov-99#331Update on Tenofovir (PMPA) compassionate Access Study
access to care01-Oct-99#328ABT-378 Early Access Program Begins
access to care16-Apr-99#317San Francisco General Outpatient Pharmacy Problems
access to care19-Feb-99#313Medical Marijuana: Major AIDS Organizations Seek Legal Access
access to care19-Feb-99#313San Francisco: New HMO Problems threaten Access to Care
access to care08-Jan-99#3101999: Treatments, Issues to Watch
access, international17-Dec-99#333Medical Donations for Cuba
access, international19-Nov-99#331Seattle Trade Meeting: What Can Be Done for Treatment Access? Interview wi
access, international05-Nov-99#330Pharmaceutical Patents and Developing Countries
access, international03-Sep-99#326Activists Block Gore's Office to Protest Terms of Africa Deal
access, international03-Sep-99#326Brazil May Stop Drug Access; Problems Also Reported from Argentina
access, international03-Sep-99#326Seattle Demonstration Preparations for Global Trade Meetings
access, international06-Aug-99#324International AIDS Treatment Momentum: Interview with Paul Boneberg, Globa
access, international02-Jul-99#322Africa, Access, and Patents: Moving Fast
access, international18-Jun-99#321India Research Opportunities, Price and Patent Problems: Interview with Da
access, international04-Jun-99#320Panama: Modern Antiretroviral Treatment Will Be Available
access, international21-May-99#319Hundred Million Dollar Program for Public-Private AIDS Research and Outrea
access, international07-May-99#318Africa and HIV/AIDS: Email Communication List
access, international16-Apr-99#317New Frontier of AIDS Activism: International Trade Rules and Global Access
access, international19-Mar-99#315Health Gap Coalition--New Group for International Treatment Access
access, international05-Mar-99#314Compulsory Licensing for Bridging the Gap--Treatment Access in Developing
access, international22-Jan-99#311A Visit to India: Drug Prices, Research, & Global Access
activism17-Dec-99#333San Francisco General Hospital Funding Crisis: Call for Information
activism17-Dec-99#333Medical Donations for Cuba
activism17-Dec-99#333Northern California: One-Day Advocacy Conference, January 29
activism05-Nov-99#330Activism Today: The Coalition for Salvage Therapy. Interview with Linda Gr
activism05-Nov-99#330Pharmaceutical Patents and Developing Countries
adefovir05-Nov-99#330Adefovir: FDA Committee Votes Against Approval
adefovir15-Oct-99#329FDA Advisory Meetings: Adefovir, Nov. 1; Resistance Testing Nov. 2-3
AEGIS04-Jun-99#320AEGIS Nominated to UNESCO "Memory of the World"
Africa02-Jul-99#322Africa, Access, and Patents: Moving Fast
Africa21-May-99#319Hundred Million Dollar Program for Public-Private AIDS Research and Outrea
Africa07-May-99#318Africa and HIV/AIDS: Email Communication List
Africa19-Mar-99#315Health Gap Coalition--New Group for International Treatment Access
African American07-May-99#318Model AIDS Program Housed in African-American Church
African Growth and Opportunity Act19-Mar-99#315Health Gap Coalition--New Group for International Treatment Access
AGAPE Program07-May-99#318Model AIDS Program Housed in African-American Church
Agenerase(TM)07-May-99#318Amprenavir, New Protease Inhibitor, Approved
Agouron Pharmaceuticals07-May-99#318Model AIDS Program Housed in African-American Church
AIDS Action20-Aug-99#325AIDS Jobs Available
AIDS Research Alliance03-Dec-99#332Hydroxychloroquine+ddI+Hydroxyurea Antiretroviral Trial, AIDS Research All
AIDS Treatment News08-Jan-99#310AIDS Treatment News Financial Disclosure Update
alitretinoin19-Feb-99#313Kaposi's Sarcoma: New Topical Treatment Approved
American Foundation for AIDS Research01-Oct-99#328New AmFAR Treatment Directory Now Available
AmFAR01-Oct-99#328New AmFAR Treatment Directory Now Available
Amplicor HIV Ultrasensitive Method05-Mar-99#314Viral Load 50-Copy Test Approved
amprenavir07-May-99#318Amprenavir, New Protease Inhibitor, Approved
anti-inflammatory21-May-99#319Medical Marijuana: AIDS-Related Information in the New Federal Report
Antioch Baptist Church07-May-99#318Model AIDS Program Housed in African-American Church
Argentina03-Sep-99#326Brazil May Stop Drug Access; Problems Also Reported from Argentina
auctions19-Nov-99#331Internet Fundraising: Online Auctions ...
Balm In Gilead, Inc.07-May-99#318Model AIDS Program Housed in African-American Church
beginning treatment20-Aug-99#325San Francisco General Hospital: Studies for Patients Beginning Antiretrovi
Beier, David16-Apr-99#317Clinton/Gore Top Staffs: Pharmaceutical Background
benefits01-Oct-99#328Medicaid: You Don't Always Have to Be "Disabled"
benefits02-Apr-99#316Medicare Recipients--New Income Limits Can Increase Cash, Medical Benefits
benefits19-Feb-99#313Keep Your Medicare in Force As You Go Back to Work (What to Do and When to
Berlin patient12-Feb-99#312Restoring HIV-Specific Immunity
biological approaches17-Sep-99#327Biological Treatment Approaches, Including Tat Toxoid Vaccine: Interview w
Bombay18-Jun-99#321India Research Opportunities, Price and Patent Problems: Interview with Da
Boneberg, Paul06-Aug-99#324International AIDS Treatment Momentum: Interview with Paul Boneberg, Globa
Brazil03-Sep-99#326Brazil May Stop Drug Access; Problems Also Reported from Argentina
Bristol-Myers Squibb19-Nov-99#331ddI, d4T, Hydroxyurea; New Pancreatitis Warning
Bristol-Myers Squibb05-Nov-99#330ddI: FDA Approves Once-Daily Dosing
Bristol-Myers Squibb21-May-99#319Hundred Million Dollar Program for Public-Private AIDS Research and Outrea
Bristol-Myers Squibb07-May-99#318Model AIDS Program Housed in African-American Church
Brown & Toland07-May-99#318Managed Care Problems: San Francisco Hearing Set for May 13
bundling02-Jul-99#322Ribavirin for Hepatitis C: 80% Price Reduction Available July 9?
buyers' clubs17-Dec-99#333Buyers' Club List, December 1999
calcium05-Mar-99#314Neuropathy: Nutritional Prevention/Treatment Suggested
calendar20-Aug-99#325Upcoming Research and Treatment Conferences, Meetings
California02-Jul-99#322Medical Marijuana: California Task Force Proposes Registration System...
California02-Jul-99#322Organ Transplants: One Million Dollars for Research
cannabinoids21-May-99#319Medical Marijuana: AIDS-Related Information in the New Federal Report
cannabis17-Sep-99#327Vaporizers for Medical Marijuana
capitation22-Jan-99#311New Healthcare Economics Threaten HIV Specialization, Patient Choice, & Qu
CD8 cells15-Oct-99#329IL-2 Low dose and Treatment Interruption: Interview with Kendall A. Smith,
Cent Gardes conference05-Nov-99#330Simultaneous Conferences Last Week: Lisbon, Paris, and Kuala Lumpur
CHAMP17-Sep-99#327Vaporizers for Medical Marijuana
chloroquine03-Dec-99#332Hydroxychloroquine+ddI+Hydroxyurea Antiretroviral Trial, AIDS Research All
CHORUS database19-Feb-99#313Strategy Trials: The Answer?
Claritin18-Jun-99#321Action Alert: Drug-Patent Bill Could Cost Patients $3 Billion+...
Cleveland07-May-99#318Model AIDS Program Housed in African-American Church
clinical trials20-Aug-99#325San Francisco General Hospital: Studies for Patients Beginning Antiretrovi
clinical trials18-Jun-99#321India Research Opportunities, Price and Patent Problems: Interview with Da
clinical trials04-Jun-99#320HE2000 Begins Clinical Trials: Interview with James Frincke, Ph.D.
clinical trials04-Jun-99#320Treatment Interruption Research: The Trial Most Needed Now
clinical trials21-May-99#319REMUNE Trial Will Stop; New Trials Planned
clinical trials08-Jan-99#310Ziagen(TM) (Abacavir) Approved: Caution Essential
clinical trials, design19-Nov-99#331FDA Clarifies Rules, Allows Combining Antiretrovirals in Clinical Trials
clinical trials, design19-Feb-99#313Strategy Trials: The Answer?
clinical trials, design08-Jan-99#310Improving Drug Development: Exploratory Clinical Studies
Clinton, President William16-Apr-99#317Clinton/Gore Top Staffs: Pharmaceutical Background
Coalition for Salvage Therapy05-Nov-99#330Activism Today: The Coalition for Salvage Therapy. Interview with Linda Gr
compounding pharmacies02-Jul-99#322Ribavirin for Hepatitis C: 80% Price Reduction Available July 9?
compounding pharmacies04-Jun-99#320Threat to Compounding of Topical Testosterone, Other Pharmaceuticals: FDA
compulsory licensing16-Apr-99#317New Frontier of AIDS Activism: International Trade Rules and Global Access
compulsory licensing05-Mar-99#314Compulsory Licensing for Bridging the Gap--Treatment Access in Developing
computer security16-Jul-99#323Charges Dropped in Sex Sting; Protecting Yourself Online
conferences05-Nov-99#330Durban Conference: February Deadlines, New Track, and Community Program
conferences05-Nov-99#330Simultaneous Conferences Last Week: Lisbon, Paris, and Kuala Lumpur
conferences, meetings -- lists20-Aug-99#325Upcoming Research and Treatment Conferences, Meetings
Consumer Project on Technology16-Apr-99#317New Frontier of AIDS Activism: International Trade Rules and Global Access
Consumer Project on Technology05-Mar-99#314Compulsory Licensing for Bridging the Gap--Treatment Access in Developing
copyleft03-Dec-99#332Copyright Restrictions Block Non-English AIDS Information
copyright03-Dec-99#332Copyright Restrictions Block Non-English AIDS Information
CST (Coalition for Salvage Therapy)05-Nov-99#330Activism Today: The Coalition for Salvage Therapy. Interview with Linda...
Cuba17-Dec-99#333Medical Donations for Cuba
d4T19-Nov-99#331ddI, d4T, Hydroxyurea; New Pancreatitis Warning
Davies Medical Center07-May-99#318Managed Care Problems: San Francisco Hearing Set for May 13
ddI03-Dec-99#332Hydroxychloroquine+ddI+Hydroxyurea Antiretroviral Trial, AIDS Research All
ddI19-Nov-99#331ddI, d4T, Hydroxyurea; New Pancreatitis Warning
ddI05-Nov-99#330ddI: FDA Approves Once-Daily Dosing
developing countriessee: access, international
diarrhea06-Aug-99#324Diarrhea: New Treatment Option from Shaman
diclofenac sodium18-Jun-99#321Neuropathy: Call for Info on Voltaren Emulgel (Topical Diclofenac Sodium)
dietary supplements06-Aug-99#324FDA Hearing Highlights Opposition to Dietary Supplement Practices...
dietary supplements18-Jun-99#321FDA Public Meeting on Dietary Supplement Regulation...
disability01-Oct-99#328Medicaid: You Don't Always Have to Be "Disabled"
disability21-May-99#319Medicaid Early Treatment Bill Now in Congress
disclosure08-Jan-99#310AIDS Treatment News Financial Disclosure Update
DSHEA06-Aug-99#324FDA Hearing Highlights Opposition to Dietary Supplement Practices...
DSHEA18-Jun-99#321FDA Public Meeting on Dietary Supplement Regulation...
Durban05-Nov-99#330Durban Conference: February Deadlines, New Track, and Community Program
email lists03-Dec-99#332Treatment and Related AIDS Email Lists
email lists07-May-99#318Africa and HIV/AIDS: Email Communication List
email lists07-May-99#318U.S. Vaccine Trial: New Email List
employment20-Aug-99#325AIDS Jobs Available
emulgel18-Jun-99#321Neuropathy: Call for Info on Voltaren Emulgel (Topical Diclofenac Sodium)
FDA19-Nov-99#331FDA Clarifies Rules, Allows Combining Antiretrovirals in Clinical Trials
FDA19-Nov-99#331ddI, d4T, Hydroxyurea; New Pancreatitis Warning
FDA05-Nov-99#330Adefovir: FDA Committee Votes Against Approval
FDA05-Nov-99#330ddI: FDA Approves Once-Daily Dosing
FDA15-Oct-99#329FDA Advisory Meetings: Adefovir, Nov. 1; Resistance Testing Nov. 2-3
FDA06-Aug-99#324FDA Hearing Highlights Opposition to Dietary Supplement Practices...
FDA18-Jun-99#321FDA Public Meeting on Dietary Supplement Regulation...
FDA04-Jun-99#320Threat to Compounding of Topical Testosterone, Other Pharmaceuticals: FDA
financial disclosure08-Jan-99#310AIDS Treatment News Financial Disclosure Update
fish oil16-Apr-99#317Fish Oil Reduced Heart Disease in Controlled Trial
foreign assistance06-Aug-99#324International AIDS Treatment Momentum: Interview with Paul Boneberg, Globa
funding06-Aug-99#324International AIDS Treatment Momentum: Interview with Paul Boneberg, Globa
funding08-Jan-99#310AIDS Treatment News Financial Disclosure Update
fundraising19-Nov-99#331Internet Fundraising: Online Auctions ...
GAAN06-Aug-99#324International AIDS Treatment Momentum: Interview with Paul Boneberg, Globa
Gallo, Robert17-Sep-99#327Biological Treatment Approaches, Including Tat Toxoid Vaccine: Interview w
Gallo, Robert19-Mar-99#315New Antiviral Substances Found with HCG
Gates, William H07-May-99#318Gates Foundation Donates $25 Million for AIDS Vaccines
Geigy Pharmaceuticals18-Jun-99#321Neuropathy: Call for Info on Voltaren Emulgel (Topical Diclofenac Sodium)
generic drugs18-Jun-99#321India Research Opportunities, Price and Patent Problems: Interview with Da
genotypic testing02-Apr-99#316Viral Resistance Testing: Practical Issues and Future Opportunities--Inter
Getty, Jeff02-Jul-99#322Organ Transplants: One Million Dollars for Research
Gilead Sciences19-Nov-99#331Update on Tenofovir (PMPA) compassionate Access Study
Gilead Sciences05-Nov-99#330Adefovir: FDA Committee Votes Against Approval
Glaxo Wellcome07-May-99#318Amprenavir, New Protease Inhibitor, Approved
Glaxo Wellcome19-Mar-99#315Lipodystrophy: Glaxo Researchers Suggest Mechanisms, Publish Data
Glide-Goodlett HIV/AIDS Project07-May-99#318Model AIDS Program Housed in African-American Church
Global AIDS Action Network06-Aug-99#324International AIDS Treatment Momentum: Interview with Paul Boneberg, Globa
Gore, Vice President Al03-Sep-99#326Activists Block Gore's Office to Protest Terms of Africa Deal
Gore, Vice President Al02-Jul-99#322Africa, Access, and Patents: Moving Fast
Gore, Vice President Al16-Apr-99#317Clinton/Gore Top Staffs: Pharmaceutical Background
Gore, Vice President Al16-Apr-99#317New Frontier of AIDS Activism: International Trade Rules and Global Access
Green, Chris03-Dec-99#332Copyright Restrictions Block Non-English AIDS Information
guidelines03-Sep-99#326Opportunistic Infections: New Treatment Guidelines Published August 20
guidelines21-May-99#319Updated HIV Treatment Guidelines Available
HCG19-Mar-99#315New Antiviral Substances Found with HCG
HE200004-Jun-99#320HE2000 Begins Clinical Trials: Interview with James Frincke, Ph.D.
Health Gap Coalition18-Jun-99#321India Research Opportunities, Price and Patent Problems: Interview with Da
Health Gap Coalition19-Mar-99#315Health Gap Coalition--New Group for International Treatment Access
heart disease16-Apr-99#317Fish Oil Reduced Heart Disease in Controlled Trial
hepatitis C02-Jul-99#322Ribavirin for Hepatitis C: 80% Price Reduction Available July 9?
HIV Treatment Data Project19-Feb-99#313Strategy Trials: The Answer?
HIV-specific immunity19-Nov-99#331Restoring HIV-Specific Immunity: Telephone Conference December 8
HIV-specific immunity12-Feb-99#312HIV-Specific Immunity: Major Conference Sessions
HIV-specific immunity12-Feb-99#312Restoring HIV-Specific Immunity
HIV-specific immunity08-Jan-99#3101999: Treatments, Issues to Watch
HMOs19-Feb-99#313San Francisco: New HMO Problems threaten Access to Care
HMOs22-Jan-99#311New Healthcare Economics Threaten HIV Specialization, Patient Choice, & Qu
Hollis Eden04-Jun-99#320HE2000 Begins Clinical Trials: Interview with James Frincke, Ph.D.
HOPE for Africa Act19-Mar-99#315Health Gap Coalition--New Group for International Treatment Access
human chorionic gonadotropin19-Mar-99#315New Antiviral Substances Found with HCG
human rights06-Aug-99#324International AIDS Treatment Momentum: Interview with Paul Boneberg, Globa
hydroxychloroquine03-Dec-99#332Hydroxychloroquine+ddI+Hydroxyurea Antiretroviral Trial, AIDS Research All
hydroxyurea03-Dec-99#332Hydroxychloroquine+ddI+Hydroxyurea Antiretroviral Trial, AIDS Research All
hydroxyurea19-Nov-99#331ddI, d4T, Hydroxyurea; New Pancreatitis Warning
hydroxyurea07-May-99#318Interrupting HAART; Hydroxyurea; Five+ Drug Therapy--Report from the RIGHT
hypersensitivity reaction08-Jan-99#310Ziagen(TM) (Abacavir) Approved: Caution Essential
IAVI07-May-99#318Gates Foundation Donates $25 Million for AIDS Vaccines
ICAAC01-Oct-99#328ICAAC Conference Reports on Web
ICAAC01-Oct-99#328ICAAC: New Drugs in Late Breaker Session
IL-2, low dose15-Oct-99#329IL-2 Low dose and Treatment Interruption: Interview with Kendall A. Smith,
Immune Response Corporation21-May-99#319REMUNE Trial Will Stop; New Trials Planned
immune system20-Aug-99#325Poppers: More Evidence of Suppressed Immunity
immune system16-Apr-99#317T-Cell A